Related Experiment Video
Updated: Jul 18, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Hepatic sarcoidosis
Alexandros Karagiannidis1, Maria Karavalaki, Anastasios Koulaouzidis
1Specialist Registrar in Gastroenterology, AHEPA General Hospital, Thessaloniki, Greece.
Abstract:
Sarcoidosis is a multisystem disease of unknown aetiology. Histological evidence of non-caseating granulomas represents the main finding. It affects mostly young people, targeting primary the lung and hilar lymph nodes although liver involvement is often encountered. Hepatic sarcoidosis covers a broad spectrum from asymptomatic hepatic granulomas formation and slightly deranged liver function tests to clinically evident disease with cholestasis or, in advanced cases, cirrhosis and portal hypertension. Other granulomatous diseases (mainly systemic infections like tuberculosis) should be excluded prior to treatment, as longstanding corticosteroid administration is the main stem of therapy. In advanced cases, liver transplantation represents the ultimate therapeutic option.
Related Concept Videos
Cirrhosis I: Introduction
Cirrhosis II: Pathophysiology
Hepatitis
Hepatic Portal System
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is responsible...
Hepatic Encephalopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
